Lessons Learned from Donor Cell-Derived Myeloid Neoplasms: Report of Three Cases and Review of the Literature

Donor-cell derived myeloid neoplasm (DDMN), a rare complication after allogeneic hematopoietic cell transplantation (HCT), is of interest for its potential to reveal donor-derived and host-derived factors that contribute to the pathogenesis of leukemia. The accurate diagnosis of donor-derived leukem...

Full description

Bibliographic Details
Main Authors: Komal Galani Deshmukh, Katalin Kelemen
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/12/4/559
_version_ 1797410441622716416
author Komal Galani Deshmukh
Katalin Kelemen
author_facet Komal Galani Deshmukh
Katalin Kelemen
author_sort Komal Galani Deshmukh
collection DOAJ
description Donor-cell derived myeloid neoplasm (DDMN), a rare complication after allogeneic hematopoietic cell transplantation (HCT), is of interest for its potential to reveal donor-derived and host-derived factors that contribute to the pathogenesis of leukemia. The accurate diagnosis of donor-derived leukemias has been facilitated by the more frequent use of molecular techniques. In this study, we describe three additional cases of DDMN; the first reported case of donor-derived chronic myelomonocytic leukemia (CMML), one acute myeloid leukemia (AML) with t(8;21)(q22;22); <i>RUNX1-RUNX1T1</i> and one donor-derived MDS with deletion 5q. A review of the cytogenetic profiles of previously reported DDMN indicates a significant contribution of therapy-related myeloid neoplasms. Cases with direct evidence of donor- or recipient-dependent factors are rare; a role of direct transfer of leukemic cells, genomic instability of the donor, abnormal gene methylation in donor cells, proleukemic potential of abnormal stromal niche, and the role of immunological surveillance after transplantation has been observed. The role of additional potential pathogenetic factors that are without clinically observed evidence are also reviewed.
first_indexed 2024-03-09T04:30:04Z
format Article
id doaj.art-acca5f0b7c534782a8fb7bb70649c167
institution Directory Open Access Journal
issn 2075-1729
language English
last_indexed 2024-03-09T04:30:04Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series Life
spelling doaj.art-acca5f0b7c534782a8fb7bb70649c1672023-12-03T13:37:16ZengMDPI AGLife2075-17292022-04-0112455910.3390/life12040559Lessons Learned from Donor Cell-Derived Myeloid Neoplasms: Report of Three Cases and Review of the LiteratureKomal Galani Deshmukh0Katalin Kelemen1Star Superspeciality Hospital, Nagpur 440012, IndiaDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ 85054, USADonor-cell derived myeloid neoplasm (DDMN), a rare complication after allogeneic hematopoietic cell transplantation (HCT), is of interest for its potential to reveal donor-derived and host-derived factors that contribute to the pathogenesis of leukemia. The accurate diagnosis of donor-derived leukemias has been facilitated by the more frequent use of molecular techniques. In this study, we describe three additional cases of DDMN; the first reported case of donor-derived chronic myelomonocytic leukemia (CMML), one acute myeloid leukemia (AML) with t(8;21)(q22;22); <i>RUNX1-RUNX1T1</i> and one donor-derived MDS with deletion 5q. A review of the cytogenetic profiles of previously reported DDMN indicates a significant contribution of therapy-related myeloid neoplasms. Cases with direct evidence of donor- or recipient-dependent factors are rare; a role of direct transfer of leukemic cells, genomic instability of the donor, abnormal gene methylation in donor cells, proleukemic potential of abnormal stromal niche, and the role of immunological surveillance after transplantation has been observed. The role of additional potential pathogenetic factors that are without clinically observed evidence are also reviewed.https://www.mdpi.com/2075-1729/12/4/559donor cell-derived leukemiamyeloid neoplasmhematopoietic stem cell transplantationtherapy-related myeloid neoplasmcytogenetic findingsbone marrow niche
spellingShingle Komal Galani Deshmukh
Katalin Kelemen
Lessons Learned from Donor Cell-Derived Myeloid Neoplasms: Report of Three Cases and Review of the Literature
Life
donor cell-derived leukemia
myeloid neoplasm
hematopoietic stem cell transplantation
therapy-related myeloid neoplasm
cytogenetic findings
bone marrow niche
title Lessons Learned from Donor Cell-Derived Myeloid Neoplasms: Report of Three Cases and Review of the Literature
title_full Lessons Learned from Donor Cell-Derived Myeloid Neoplasms: Report of Three Cases and Review of the Literature
title_fullStr Lessons Learned from Donor Cell-Derived Myeloid Neoplasms: Report of Three Cases and Review of the Literature
title_full_unstemmed Lessons Learned from Donor Cell-Derived Myeloid Neoplasms: Report of Three Cases and Review of the Literature
title_short Lessons Learned from Donor Cell-Derived Myeloid Neoplasms: Report of Three Cases and Review of the Literature
title_sort lessons learned from donor cell derived myeloid neoplasms report of three cases and review of the literature
topic donor cell-derived leukemia
myeloid neoplasm
hematopoietic stem cell transplantation
therapy-related myeloid neoplasm
cytogenetic findings
bone marrow niche
url https://www.mdpi.com/2075-1729/12/4/559
work_keys_str_mv AT komalgalanideshmukh lessonslearnedfromdonorcellderivedmyeloidneoplasmsreportofthreecasesandreviewoftheliterature
AT katalinkelemen lessonslearnedfromdonorcellderivedmyeloidneoplasmsreportofthreecasesandreviewoftheliterature